Volume (mm3) | SUVmean | SUVmax | ||||
Length of treatment | Before | After | Before | After | Before | After |
2 d | ||||||
Cediranib (n = 6) | 330 ± 63 | 345 ± 53 | 0.52 ± 0.04 | 0.39 ± 0.08 | 0.96 ± 0.09 | 0.73 ± 0.18 |
P | 0.67 | 0.01* | 0.03* | |||
Vehicle (n = 5) | 526 ± 378 | 518 ± 422 | 0.53 ± 0.05 | 0.49 ± 0.07 | 1.05 ± 0.15 | 1.00 ± 0.20 |
P | 0.98 | 0.11 | 0.36 | |||
7 d | ||||||
Cediranib (n = 6) | 700 ± 297 | 604 ± 248 | 0.56 ± 0.17 | 0.38 ± 0.08 | 0.99 ± 0.32 | 0.71 ± 0.19 |
P | 0.56 | 0.01 | 0.01* | |||
Vehicle (n = 4) | 577 ± 556 | 931 ± 982 | 0.58 ± 0.18 | 0.52 ± 0.21 | 1.07 ± 0.31 | 0.92 ± 0.46 |
P | 0.55 | 0.40 | 0.30 |
↵* Statistically significant.